Home/F-star Therapeutics/Eliot Forster, Ph.D.
EF

Eliot Forster, Ph.D.

Former Chief Executive Officer

F-star Therapeutics

Therapeutic Areas

F-star Therapeutics Pipeline

DrugIndicationPhase
FS118Metastatic, PD-1 resistant cancers (e.g., Head & Neck, DLBCL)Phase 2
FS222Advanced solid tumorsPhase 1
FS120Advanced solid tumorsPhase 1